Takeda to float 7.5bn euros in bonds to fund Shire purchase

$5.5bn bond issuance also in the works as company refinances short-term debt

Takeda's Shire purchase is the most expensive acquisition by a Japanese company.

SHINYA ABE, Nikkei staff writer

November 17, 2018 02:11 JST

TOKYO -- Takeda Pharmaceutical is set to issue 7.5 billion euros ($8.55 billion) of bonds next week to help pay for the $62 billion purchase of Irish drugmaker Shire.

The Japanese company announced on Friday the terms of the bond issuance. Six tranches with maturities of two, four, eight and 12 years will be issued this coming Wednesday. Coupon rates will be 2.25% for the eight-year bonds and 3% for the 12-year bonds.